577 related articles for article (PubMed ID: 5508247)
1. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity.
Wu TT; Kabat EA
J Exp Med; 1970 Aug; 132(2):211-50. PubMed ID: 5508247
[TBL] [Abstract][Full Text] [Related]
2. Comparison of invariant residues in the variable and constant regions of human K, human L, and mouse K Bence-Jones proteins.
Kabat EA
Proc Natl Acad Sci U S A; 1967 Jul; 58(1):229-33. PubMed ID: 5231603
[No Abstract] [Full Text] [Related]
3. Some correlations between specificity and sequence of the first complementarity-determining segments of human kappa light chains.
Kabat EA; Wu TT; Bilofsky H
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4471-3. PubMed ID: 826908
[TBL] [Abstract][Full Text] [Related]
4. Primary structure of the variable part of an amyloidogenic Bence-Jones Protein (Mev.). An unusual insertion in the third hypervariable region of a human kappa-immunoglobulin light chain.
Eulitz M; Linke RP
Hoppe Seylers Z Physiol Chem; 1982 Nov; 363(11):1347-58. PubMed ID: 6816713
[TBL] [Abstract][Full Text] [Related]
5. Rabbit antibody with light chain having an N-terminal valyl residue.
Seon BK; Roholt OA; Pressman D
Immunochemistry; 1971 Jul; 8(7):585-92. PubMed ID: 4108805
[No Abstract] [Full Text] [Related]
6. Novel human light chain V kappa segment: serologic and structural analyses of the kappa III-like Bence Jones protein and IgG kappa light chain REE.
Prelli F; Tummolo D; Solomon A; Frangione B
J Immunol; 1986 Jun; 136(11):4169-73. PubMed ID: 2422275
[TBL] [Abstract][Full Text] [Related]
7. Pillars article: an analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 1970. 132: 211-250.
Wu TT; Kabat EA
J Immunol; 2008 Jun; 180(11):7057-96. PubMed ID: 18490705
[No Abstract] [Full Text] [Related]
8. Study of the frequency of kappa and lambda light chains in 347 sera containing a monoclonal IgG, IgA, IgD, or Bence-Jones protein.
Fine JM
Rev Eur Etud Clin Biol; 1970 Feb; 15(2):199-202. PubMed ID: 4192027
[No Abstract] [Full Text] [Related]
9. Amino acid sequence of an amyloidogenic Bence Jones protein in myeloma-associated systemic amyloidosis.
Tonoike H; Kametani F; Hoshi A; Shinoda T; Isobe T
FEBS Lett; 1985 Jun; 185(1):139-41. PubMed ID: 3922791
[TBL] [Abstract][Full Text] [Related]
10. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).
Solomon A; Frangione B; Franklin EC
J Clin Invest; 1982 Aug; 70(2):453-60. PubMed ID: 6808027
[TBL] [Abstract][Full Text] [Related]
11. Idiotypical identity of IgG myeloma protein with monoclonal IgM, Bence Jones protein, and Fv derived from one patient.
Miyagawa N; Morita K; Azuma T
Microbiol Immunol; 1990; 34(9):787-94. PubMed ID: 1704478
[TBL] [Abstract][Full Text] [Related]
12. A human kappa Bence Jones protein (subgroup I) showing new amino acid substitutions.
Matthews JB; Jefferis R
Immunochemistry; 1977; 14(11-12):793-7. PubMed ID: 413784
[No Abstract] [Full Text] [Related]
13. The V region sequence of lambda Bence-Jones protein Wh: evidence for separate germ-line sets within lambda-subgroups.
Kiefer CR; Patton HM; McGuire BS; Garver FA
J Immunol; 1980 Jan; 124(1):301-6. PubMed ID: 7350229
[TBL] [Abstract][Full Text] [Related]
14. [Myeloma as a tool for elucidation of the mechanism of antibody diversity].
Laskov R
Harefuah; 1972 Jan; 82(2):78-85. PubMed ID: 4565408
[No Abstract] [Full Text] [Related]
15. Carboxy-terminal structure of the chain of human IgA myeloma proteins.
Prahl JW; Abel CA; Grey HM
Biochemistry; 1971 May; 10(10):1808-12. PubMed ID: 4998234
[No Abstract] [Full Text] [Related]
16. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
Frangione B; Moloshok T; Solomon A
J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
[TBL] [Abstract][Full Text] [Related]
17. Novel arrangement of immunoglobulin variable domains: X-ray crystallographic analysis of the lambda-chain dimer Bence-Jones protein Loc.
Chang CH; Short MT; Westholm FA; Stevens FJ; Wang BC; Furey W; Solomon A; Schiffer M
Biochemistry; 1985 Aug; 24(18):4890-7. PubMed ID: 3935155
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma with serum IgM kappa and Bence Jones lambda biclonal gammopathy.
Graziani MS; Lippi U
Clin Chem; 1986 Dec; 32(12):2220-1. PubMed ID: 3096615
[TBL] [Abstract][Full Text] [Related]
19. Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains.
Kabat EA; Wu TT
Ann N Y Acad Sci; 1971 Dec; 190():382-93. PubMed ID: 5290024
[No Abstract] [Full Text] [Related]
20. Unique features of the variable regions of Bence Jones proteins and their possible relation to antibody complementarity.
Kabat EA
Proc Natl Acad Sci U S A; 1968 Feb; 59(2):613-9. PubMed ID: 5238988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
